Relmada Therapeutics Strengthens Board of Directors with Appointments of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool - PR Newswire -BoardProspects

Relmada Therapeutics Strengthens Board of Directors with Appointments of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool

PR Newswire Dec 20 2019 BoardMoves

NEW YORK, Dec. 20, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the appointments of life sciences industry veterans, Eric Schmidt, Ph.D., and John Glasspool, to the Company's Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Astoria Financial Corporation Announces The Resignation Of Chairman George L. Engelke, Jr. And The Appointment Of ... also published in PR Newswire
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Former Aes Ceo Paul Hanrahan Elected to Arch Coal's Board of Directors also published in PR Newswire
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned